CarMax reported lower sales, but the company is encouraged by more affordable prices.
Sarapeta Therapeutics Inc.’s stock soared 38% in premarket trade Friday, after the biotech said the U.S. regulator has approved an expanded indication of its treatment for the rare muscle disorder Duchenne muscular dystrophy.
Treasury yields were falling on Friday, as investors looked ahead to existing home sales and other data.
As veterans retire, freshly minted advisers in their 20s and 30s are replacing them.
Tech-savvy Gen Z consumers are forcing retailers to adapt to their digital life.
Morgan Stanley’s Michael Mauboussin has cultivated a loyal following over his nearly four decades on Wall Street. He joined MarketWatch for a brief interview earlier this week.
Short positions in popular assets are at record lows, implying a bet that volatility will stay low.
Justin Trudeau has faced pressure to match the positions of the U.S. and European Union by hiking tariffs on imported Chinese EVs
